Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This is an open label, 2-period, fixed-sequence study in 15 healthy adult subjects under fed
conditions. To evaluate the effect of multiple doses of lansoprazole on the absorption and
pharmacokinetics (PK) of a single dose of neratinib in healthy subjects.